A phase IB and randomised phase IIA trial of CApecitabine plus Radium-223 (Xofigoâ„¢) in breast cancer patients with BONe metastases: CARBON trial results. (2022)
Attributed to:
Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2022.100442
PubMed Identifier: 35800293
Publication URI: http://europepmc.org/abstract/MED/35800293
Type: Journal Article/Review
Volume: 35
Parent Publication: Journal of bone oncology
ISSN: 2212-1366